1. Chen, Juhui, Zhang, Jingshi, Hong, Liang, Zhou, Yongtao. . EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma. In Cancer biomarkers : section A of Disease markers, 24, 343-350. doi:10.3233/CBM-181740. https://pubmed.ncbi.nlm.nih.gov/30829611/
2. Yang, Hao, Gou, Xinyi, Feng, Caizhen, Cheng, Jin, Gao, Bo. 2024. Overall survival prediction of gastric cancer using the gene signature of CT-detected extramural venous invasion combined with M2 macrophages infiltration. In Journal of translational medicine, 22, 829. doi:10.1186/s12967-024-05628-3. https://pubmed.ncbi.nlm.nih.gov/39252063/
3. Li, Kaishu, Zhu, Qihui, Du, Siyuan, Jin, Hong, Qi, Ling. 2024. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma. In International immunopharmacology, 138, 112625. doi:10.1016/j.intimp.2024.112625. https://pubmed.ncbi.nlm.nih.gov/38996666/
4. Lu, Yanqiao, Huo, Huanhuan, Liang, Feng, Shen, Lan, He, Ben. 2023. Role of Pericytes in Cardiomyopathy-Associated Myocardial Infarction Revealed by Multiple Single-Cell Sequencing Analysis. In Biomedicines, 11, . doi:10.3390/biomedicines11112896. https://pubmed.ncbi.nlm.nih.gov/38001896/
5. Wang, Jinsong, Feng, Jia, Chen, Xinyi, Zhan, Yujie, Peng, Min. 2024. Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer. In Aging, 16, 7331-7356. doi:10.18632/aging.205760. https://pubmed.ncbi.nlm.nih.gov/38656888/